Skip to content
Pharma Observatory a Scientist.com platform

Organization (Industry)

Symrise AG

ClinicalTrials.gov lists Symrise AG as lead sponsor of 21 trials, counting the companies grouped under it.

DE Industry Manufacturer
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Companies grouped under this page Companies grouped under this page 2 Disease areas Disease areas 11 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 3 Journals published in Journals published in 9 US granted patents US granted patents 1 FDA inspection record FDA inspection record 1 FDA import refusals FDA import refusals 1 Manufacturing and distribution sites Manufacturing and distribution sites 3 Companies grouped under this page Companies grouped under this page 2 Disease areas Disease areas 11 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 3 Journals published in Journals published in 9 US granted patents US granted patents 1 FDA inspection record FDA inspection record 1 FDA import refusals FDA import refusals 1 Manufacturing and distribution sites Manufacturing and distribution sites 3

Rows recorded per section

1 more section with rows · 15 sections measured, none recorded

Logo Symrise AG, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.

This page covers Symrise AG and 2 companies grouped under it: 21 lead-sponsored trials (0 its own, 21 in the grouped companies) and 6 legal-entity registrations (3 its own, 3 in the grouped companies).

Get the Symrise AG report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Companies grouped under this page (2)

Shown in this order: most lead trials first.

Companies grouped under this page
Company Lead trials Legal entities
Probi 21 2
Symrise S. de R.L. de C.V 0 1

Disease areas (11)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Attention Deficit Disorder with Hyperactivity 1
Bone Diseases, Metabolic 1
Common Cold 1
Cross Infection 1
Diarrhea 1

Showing 5 of 11 disease areas.

Start your 14-day trial Email me all 11 disease areas as a PDF

Trials by start year as sponsor or collaborator (3)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 1
2021 1
2018 1

No forecast is made for this organization: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.

The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

Journals published in (9)

Shown in this order: most published in first.

Journals published in
Journal Publications
Critical care (London, England) 2
MicrobiologyOpen 1
Molecular nutrition & food research 1
PloS one 1
Probiotics and antimicrobial proteins 1

Showing 5 of 9 journals.

Start your 14-day trial Email me all 9 journals as a PDF

US granted patents (1)

Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.

US granted patents
US patents granted Granted in the last 5 years Most recent grant
349 95 2025-12-23

FDA inspection record (1)

FDA inspection record
Latest classification Inspections
NAI 6

FDA import refusals (1)

FDA import refusals
Refused import lines Latest refusal
4 2021-06-22

Manufacturing and distribution sites (3)

Shown in this order: severity rank then name.

Manufacturing and distribution sites
Facility Location Regulators Member organization
Symrise, S. DE R.L.DE C.V. San Nicolas De Los Garza, MX FDA, Health Canada Symrise, S. DE R.L.DE C.V.
Symrise, Inc. Goose Creek, US FDA, Health Canada Symrise, Inc.
Symrise AG Holzminden, DE EMA, FDA, Health Canada

Latest dated events (395)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-05-25 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-05-21 FDA inspection FDA enforcement (warning and untitled letters, recalls, inspections, import refusals, debarment)
2026-02-23 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-12-23 Patent granted Granted US patents (PatentsView / USPTO)
2025-12-09 Patent granted Granted US patents (PatentsView / USPTO)

Showing 5 of 395 events.

Start your 14-day trial Email me the first 50 events as a PDF

On Scientist.com

Symrise AG is listed as a research supplier in the Scientist.com network.

Symrise supplies fragrances, flavorings, cosmetic active ingredients, raw materials and functional ingredients.

Website
www.symrise.com/en

Source: Scientist.com supplier network

Not on this page

Checked, with nothing recorded for this organization: related companies not grouped here, active development programs, approved assets, sponsor delivery record, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda recalls, climate targets, as filed, workforce and board diversity, as filed, organization relationships, clia clinical laboratory certificates, biomarker capability evidence, and biomarkers this organization publishes on.

Work with Symrise on Scientist.com

For prices, more details, or to contact Symrise, visit Scientist.com.

View on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.